Abstract
Background: Studies of long-term intake of industrially produced trans fatty acids (TFA) and n-3 polyunsaturated fatty acids (PUFA) suggest opposite effects on cardiovascular disease risk. Common mechanisms of action are probable.
Objective: To examine the effects on cardiovascular risk markers of dietary enrichment with TFA or n-3 PUFA.
Design: Randomized, double-blind, parallel intervention trial.
Setting: Department of Human Nutrition, The Royal Veterinary and Agricultural University.
Subjects: In all, 87 healthy males included, 79 completed.
Intervention: Subjects were randomly assigned to 8 weeks of a daily intake of 33 g of experimental fats from either partially hydrogenated soy oil containing 20 g of TFA, 12 g of fish oil with approximately 4 g of n-3 PUFA and 21 g of control fat, or 33 g of control fat. The experimental fats were incorporated into bakery products. Plasma lipids, blood pressure, heart rate variability (HRV), arterial dilatory capacity, compliance, and distensibility were recorded before and after intervention and at follow-up 12 weeks after the intervention.
Results: High-density lipoprotein cholesterol (HDL-C) decreased in the TFA group and triglycerides and mean arterial blood pressure decreased in the n-3 PUFA group compared to the control group. HRV, arterial dilatory capacity, compliance, and distensibility were unchanged.
Conclusion: The results indicate that the association between coronary heart disease risk and intake of TFA and n-3 PUFA relates only modestly to changes in traditional risk markers.
Sponsorship: Danish Medical Research Council (Grant no. 22-01-0390), Center of Advanced Food Research (Copenhagen, Denmark) (Grant no. KVL-R-2001-107), the Danish Heart Association (Grant no. 99-2-3-45-22748), Novozymes (Bagsvaerd, Denmark), Aarhus Olie (Aarhus, Denmark), and from private sources. The experimental fats were provided by Pronova Biocare (Aalesund, Norway) and Aarhus Olie (Aarhus, Denmark).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials
European Journal of Clinical Nutrition Open Access 28 December 2017
-
A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals
Lipids in Health and Disease Open Access 06 June 2015
-
Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women
Nutrition & Diabetes Open Access 31 January 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
(2002): Regulations Amending the Food and Drug Regulations (Nutrition Labelling, Nutrient Content Claims and Health Claims). Canad. Gazette 137, 154–403.
Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC & Ma J (2002): Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346, 1113–1118.
Ascherio A, Katan MB, Zock PL, Stampfer MJ & Willett WC (1999): Trans fatty acids and coronary heart disease. N. Engl. J. Med. 340, 1994–1998.
Ascherio A, Rimm EB, Giovannucci EL, Spiegelman D, Stampfer M & Willett WC (1996): Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313, 84–90.
Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC & Deadman NM (1989): Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2, 757–761.
Camm AJ, Malik M, Bigger JT Jr, Breithardt G, Cerutti S, Cohen RJ, Coumel P, Fallen EL, Kennedy HL, Kleiger RE, Lombardi F, Malliani A, Moss AJ, Rottman JN, Schmidt G, Schwartz PJ & Singer DH (1996): Heart rate variability: standards of measurement, physiological interpretation and clinical use Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93, 1043–1065.
Christensen JH, Christensen MS, Dyerberg J & Schmidt EB. (1999): Heart rate variability and fatty acid content of blood cell membranes: a dose–response study with n-3 fatty acids. Am. J. Clin. Nutr. 70, 331–337.
Christensen JH, Skou HA, Fog L, Hansen V, Vesterlund T, Dyerberg J, Toft E & Schmidt EB (2001a): Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 103, 651–657.
Clausen P, Jensen JS, Jensen G, Borch-Johnsen K & Feldt-Rasmussen B. (2001): Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 103, 1869–1874.
Curtis BM & O'Keefe Jr JH (2002): Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin. Proc. 77, 45–54.
de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J & Mamelle N (1999): Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99, 779–785.
de Roos NM, Bots ML & Katan MB (2001): Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler. Thromb. Vasc. Biol. 21, 1233–1237.
Food and Nutrition Board (2002): Letter report on dietary reference intakes from trans fattty acids. Institute of Medicine, National Academy of Sciences 1–23.
Goodfellow J., Bellamy MF, Ramsey MW, Jones CJ & Lewis MJ (2000): Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J. Am. Coll. Cardiol. 35, 265–270.
Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ & Stamler J (1999): Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am. J. Epidemiol. 149, 853–862.
Harris WS (1997): n-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65, 1645S–1654S.
Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH & Willett WC (1997): Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 337, 1491–1499.
Kannel WB, Kannel C, Paffenbarger Jr RS & Cupples LA (1987): Heart rate and cardiovascular mortality: the Framingham Study. Am. Heart J. 113, 1489–1494.
Katz AM (2002): Trans-fatty acids and sudden cardiac death. Circulation 105, 669–671.
Kleiger RE, Bigger JT, Bosner MS, Chung MK, Cook JR, Rolnitzky LM, Steinman R & Fleiss JL (1991): Stability over time of variables measuring heart rate variability in normal subjects. Am. J. Cardiol. 68, 626–630.
Kris-Etherton PM, Harris WS & Appel LJ (2002): Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
Kristiansen PH & Koch B (2003): Bekendtgørelse om indhold af transfedtsyrer i olie og fedtstoffer mv. The Danish Veterinary and food Administration Bek. nr. 160.
Lemaitre RN, King IB, Raghunathan TE, Pearce RM, Weinmann S, Knopp RH, Copass MK, Cobb LA & Siscovick DS (2002): Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 105, 697–701.
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C & Valagussa F (2002): Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105, 1897–1903.
Mauger J-F, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C & Lamarche B (2003): Effect of different forms of dietary hydrogenated fats on LDL particle size. Am. J. Clin. Nutr. 78, 370–375.
Mensink RP, de Louw MH & Katan MB (1991): Effects of dietary trans fatty acids on blood pressure in normotensive subjects. Eur. J. Clin. Nutr. 45, 375–382.
Nestel P, Shige H, Pomeroy S, Cehun M, Abbey M & Raederstorff D (2002): The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am. J. Clin. Nutr. 76, 326–330.
Oomen CM, Ocke MC, Feskens EJ, Erp-Baart MA, Kok FJ & Kromhout D (2001): Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357, 746–751.
Patel AJ, Lazdunski M & Honore E. (2001): Lipid and mechanogated 2P domain K(+) channels. Curr. Opin. Cell Biol. 13, 422–428.
Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D & Virtamo J. (1997): Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am. J. Epidemiol. 145, 876–887.
Reunanen A, Karjalainen J, Ristola P, Heliovaara M, Knekt P & Aromaa A. (2000): Heart rate and mortality. J. Intern. Med. 247, 231–239.
Stender S, Dyerberg J, Holmer G, Ovesen L & Sandstrom B. (1995): The influence of trans fatty acids on health: a report from the Danish Nutrition Council. Clin. Sci. (Lond) 88, 375–392.
Valagussa F, Franzosi MG, Geraci E, Mininni N, Nicolosi GL, Santini M, Tavazzi L, Vecchio C, Marchioli R, Bomba E, Chieffo C, Maggioni AP, Schweiger C, Tognoni G, Barzi F, Flamminio AV, Marfisi RM, Olivieri M, Pera C, Polidoro A, Santoro E, Zama R, Pagliaro L, Correale E, Del Favero A, Loi U, Marubini E, Campolo L, Casari A, Di Minno G, Donati MB, Galli M, Gattone M, Garattini S, Mancini M, Marino P, Santoro GM, Scardulla C, Specchia G, Cericola A, Di Gregorio D, Di Mascio R, Levantesi G, Mantini L, Mastrogiuseppe G, Tucci C, Mocarelli P, Baldinelli R, Ceriotti F, Colonna A, Cortese C, Fortunato G, Franzini C, Gonano F & Graziani MS (1999): Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447–455.
Van Poppel G (1998): Intake of trans fatty acids in Western Europe: the TRANSFAIR study. Lancet 351, 1099.
Wiinberg N (2000): Measurement of arterial compliance in vivo. Stud. Health Technol. Inform. 71, 99–108.
Wilkening V (2001): Proposed changes in USA regulations for food labeling. J Food Comp. Anal. 14, 309–314.
Acknowledgements
The technical assistance of Inge Aardestrup, Birgitte Olander, Birte Nielsen, Ella Jessen and Birthe Nielsen is highly appreciated.
Author information
Authors and Affiliations
Contributions
Guarantors: Jørn Dyerberg: Protocol design, acquisition of data, analysis and interpretation of data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, study supervision. Dorte Cecilie Eskesen: Acquisition of data, analysis and interpretation of AC and AD data, drafting of the manuscript, critical revision of the manuscript for important intellectual content, dietary counseling.
Contributors: Petra W. Andersen: Analysis and interpretation of HRV data. Arne Astrup: Critical revision of the manuscript for important intellectual content. Benjamin Buemann: Critical revision of the manuscript for important intellectual content. Jeppe Hagstrup Christensen: Analysis and interpretation of HRV data, statistical expertise, critical revision of the manuscript for important intellectual content. Peter Clausen: Acquisition, analysis and interpretation of FMD and NID data. Drafting of the manuscript, critical revision of the manuscript for important intellectual content, study supervision. Bo Feldt Rasmussen: Acquisition, analysis and interpretation of FMD and NID data. Critical revision of the manuscript for important intellectual content. Erik Berg Schmidt: Acquisition and analysis of fatty acid data. Critical revision of the manuscript for important intellectual content. Tine Tholstrup: Critical revision of the manuscript for important intellectual content, dietary counseling. Egon Toft: Critical revision of the manuscript for important intellectual content. Søren Toubro: Analysis and interpretation of data, critical revision of the manuscript for important intellectual content. Steen Stender: Protocol design, analysis and interpretation of data, critical revision of the manuscript for important intellectual content.
Corresponding author
Rights and permissions
About this article
Cite this article
Dyerberg, J., Eskesen, D., Andersen, P. et al. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr 58, 1062–1070 (2004). https://doi.org/10.1038/sj.ejcn.1601934
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601934
Keywords
- n-3 PUFA
- trans fatty acids
- heart rate variability
- arterial compliance
- arterial dilatory capacity
- plasma lipids
This article is cited by
-
Egg consumption, cardiovascular diseases and type 2 diabetes
European Journal of Clinical Nutrition (2018)
-
Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials
European Journal of Clinical Nutrition (2018)
-
A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals
Lipids in Health and Disease (2015)
-
The effect of conjugated linoleic acid, a natural trans fat from milk and meat, on human blood pressure: results from a randomized crossover feeding study
Journal of Human Hypertension (2012)
-
Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women
Nutrition & Diabetes (2011)